23.10.2014 Views

Proton Pump Inhibitors - CME Conferences

Proton Pump Inhibitors - CME Conferences

Proton Pump Inhibitors - CME Conferences

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

6 th Annual Primary Care Spring Conference Thursday, April 12, 2012<br />

FDA Requirements for Generic<br />

Ophthalmics<br />

• The following companies that offer generic latanoprost in<br />

the same formula as Xalatan include:<br />

– Brand Xalatan by Pfizer - $81.85 AWC/2.5ml 0.005% soln<br />

– Bausch + Lomb - $13.43 AWC/2.5ml 0.005% soln<br />

– Falcon Pharmaceuticals Ltd., an affiliate of Alcon Laboratories,<br />

Inc. (owned by Novartis) - $10.00 AWC/2.5ml 0.005% soln<br />

– Apotex Corp. - $53.12 AWC/2.5ml 0.005% soln<br />

– Greenstone LLC (owned by Pfizer) - $13.38 AWC/2.5ml 0.005%<br />

soln<br />

– Mylan – $6.90 AWC/2.5ml 0.005% soln<br />

– Note that all of the above have FDA Therapeutic Equivalent<br />

Codes of AT and are considered by the FDA therapeutically<br />

equivalent<br />

FDA Orange Book for Solutions<br />

• All solutions and DESI drug products containing the<br />

same active ingredient in the same topical dosage<br />

form for which a waiver of in vivo bioequivalence has<br />

been granted and for which chemistry and<br />

manufacturing processes are adequate to<br />

demonstrate bioequivalence, are considered<br />

therapeutically equivalent and coded AT.<br />

Pharmaceutically equivalent topical products that<br />

raise questions of bioequivalence, including all post-<br />

1962 non-solution topical drug products, are coded<br />

AB when supported by adequate bioequivalence<br />

data, and BT in the absence of such data.<br />

41<br />

Wayne Weart, Pharm D<br />

Cost Effective Rx

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!